Review




Structured Review

Novartis human il 2 rhil 2
Human Il 2 Rhil 2, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/2+human+il/pm42132875-357-75-79
Average 86 stars, based on 1 article reviews
human il 2 rhil 2 - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Clone Assay:

Article Title: CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Article Snippet: Cells were sorted using BD FACS Aria I or III. .. Killer cell lectin-like receptor B1 (KLRB1) gene editing of primary human T cells Expanded CD4+CD161+ cells from OPSCC tumor- infiltrating lymphocytes (TIL) or HPV16- specific CD4+CD161+ T cell clones (see online supplemental material) were thawed and rested overnight in 10% Iscove’s Modified Dulbecco’s Medium (IMDM) containing rhIL- 2 (1000 U/mL, Aldesleukin, Novartis) and rhIL- 7 (5 ng/mL) (OPSCC TIL), or rhIL2, rhIL- 7 and rhIL- 15 (5 ng/mL) (HPV16- specific T cell clones) followed by electroporation with ribonucleoproteins (RNPs) containing guide RNA (gRNA) targeting KLRB1 or control.22 CrisprRNA targeting human KLRB110 or control (catalog# 1072544) (Integrated DNA Technologies (IDT)) were suspended to 100 μM in nuclease- free duplex buffer. gRNA were generated by incubating 10 μl of 100 μM crRNA targeting KLRB1 region#1, KLRB1 region #2, or control with 10 μL tracrRNA. ..

Modification:

Article Title: CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Article Snippet: Cells were sorted using BD FACS Aria I or III. .. Killer cell lectin-like receptor B1 (KLRB1) gene editing of primary human T cells Expanded CD4+CD161+ cells from OPSCC tumor- infiltrating lymphocytes (TIL) or HPV16- specific CD4+CD161+ T cell clones (see online supplemental material) were thawed and rested overnight in 10% Iscove’s Modified Dulbecco’s Medium (IMDM) containing rhIL- 2 (1000 U/mL, Aldesleukin, Novartis) and rhIL- 7 (5 ng/mL) (OPSCC TIL), or rhIL2, rhIL- 7 and rhIL- 15 (5 ng/mL) (HPV16- specific T cell clones) followed by electroporation with ribonucleoproteins (RNPs) containing guide RNA (gRNA) targeting KLRB1 or control.22 CrisprRNA targeting human KLRB110 or control (catalog# 1072544) (Integrated DNA Technologies (IDT)) were suspended to 100 μM in nuclease- free duplex buffer. gRNA were generated by incubating 10 μl of 100 μM crRNA targeting KLRB1 region#1, KLRB1 region #2, or control with 10 μL tracrRNA. ..

Electroporation:

Article Title: CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Article Snippet: Cells were sorted using BD FACS Aria I or III. .. Killer cell lectin-like receptor B1 (KLRB1) gene editing of primary human T cells Expanded CD4+CD161+ cells from OPSCC tumor- infiltrating lymphocytes (TIL) or HPV16- specific CD4+CD161+ T cell clones (see online supplemental material) were thawed and rested overnight in 10% Iscove’s Modified Dulbecco’s Medium (IMDM) containing rhIL- 2 (1000 U/mL, Aldesleukin, Novartis) and rhIL- 7 (5 ng/mL) (OPSCC TIL), or rhIL2, rhIL- 7 and rhIL- 15 (5 ng/mL) (HPV16- specific T cell clones) followed by electroporation with ribonucleoproteins (RNPs) containing guide RNA (gRNA) targeting KLRB1 or control.22 CrisprRNA targeting human KLRB110 or control (catalog# 1072544) (Integrated DNA Technologies (IDT)) were suspended to 100 μM in nuclease- free duplex buffer. gRNA were generated by incubating 10 μl of 100 μM crRNA targeting KLRB1 region#1, KLRB1 region #2, or control with 10 μL tracrRNA. ..

Control:

Article Title: CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Article Snippet: Cells were sorted using BD FACS Aria I or III. .. Killer cell lectin-like receptor B1 (KLRB1) gene editing of primary human T cells Expanded CD4+CD161+ cells from OPSCC tumor- infiltrating lymphocytes (TIL) or HPV16- specific CD4+CD161+ T cell clones (see online supplemental material) were thawed and rested overnight in 10% Iscove’s Modified Dulbecco’s Medium (IMDM) containing rhIL- 2 (1000 U/mL, Aldesleukin, Novartis) and rhIL- 7 (5 ng/mL) (OPSCC TIL), or rhIL2, rhIL- 7 and rhIL- 15 (5 ng/mL) (HPV16- specific T cell clones) followed by electroporation with ribonucleoproteins (RNPs) containing guide RNA (gRNA) targeting KLRB1 or control.22 CrisprRNA targeting human KLRB110 or control (catalog# 1072544) (Integrated DNA Technologies (IDT)) were suspended to 100 μM in nuclease- free duplex buffer. gRNA were generated by incubating 10 μl of 100 μM crRNA targeting KLRB1 region#1, KLRB1 region #2, or control with 10 μL tracrRNA. ..

Article Title: Agonistic anti-IL-2R antibodies and methods of use
Article Snippet: .. On study day 0, each mouse was adoptively transferred IV with 20 million human PBMCs from one of the 2 donors and each mouse was treated with either vehicle control (100 μL), 22 μg rhIL-2 (350,000 UI/mice, Proleukin, Novartis) daily, 1 mg/kg BsAb-1 twice a week or 1 mg/kg BsAb-2 twice a week. ..

Generated:

Article Title: CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Article Snippet: Cells were sorted using BD FACS Aria I or III. .. Killer cell lectin-like receptor B1 (KLRB1) gene editing of primary human T cells Expanded CD4+CD161+ cells from OPSCC tumor- infiltrating lymphocytes (TIL) or HPV16- specific CD4+CD161+ T cell clones (see online supplemental material) were thawed and rested overnight in 10% Iscove’s Modified Dulbecco’s Medium (IMDM) containing rhIL- 2 (1000 U/mL, Aldesleukin, Novartis) and rhIL- 7 (5 ng/mL) (OPSCC TIL), or rhIL2, rhIL- 7 and rhIL- 15 (5 ng/mL) (HPV16- specific T cell clones) followed by electroporation with ribonucleoproteins (RNPs) containing guide RNA (gRNA) targeting KLRB1 or control.22 CrisprRNA targeting human KLRB110 or control (catalog# 1072544) (Integrated DNA Technologies (IDT)) were suspended to 100 μM in nuclease- free duplex buffer. gRNA were generated by incubating 10 μl of 100 μM crRNA targeting KLRB1 region#1, KLRB1 region #2, or control with 10 μL tracrRNA. ..

other:

Article Title: T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H.
Article Snippet: Primary T cells from healthy donors were grown in Panserin-413 (PAN-Biotech, Aidenbach, Germany) supplemented with 10% heat-inactivated pooled human serum (provided by the blood bank of UMC Mainz, Germany), 1% Penicillin/Streptomycin (Sigma Aldrich), and rhIL-2 (250-600 IU/ mL Novartis, Basel, Switzerland).

Article Title: Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression
Article Snippet: Human HD blood was obtained from the City of Hope (COH) Blood Donor Center under protocols approved by the COH Institutional Review Board (IRB).

Transduction:

Article Title: Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy
Article Snippet: Enriched Tn/mem cells from leukapheresis products were stimulated with GMP Human T-expander CD3/CD28 DynabeadsTM (Dynal Biotech Cat#11141D) at a ratio of 1:3 (T cell:bead) overnight. .. Activated T cells were subsequently transduced with CD19R(EQ):CD28:ζ/EGFRt clinical construct at MOI=1 in RPMI 1640 containing 10% FBS and 5μg/ml protamine sulfate (Fresenius Kabi, 22905), 50U/mL rhIL-2 (Novartis Pharmaceuticals, NDC0078-0495-61), and 0.5 ng/mL rhIL-15 (CellGenix, 1013-050). .. Beginning 4 days after bead stimulation, CAR T cells were treated with rapamycin (50 nmol/L) (LC Laboratories, R-5000) or vehicle (DMSO) and refreshed with media containing rapamycin or vehicle every other day.

Construct:

Article Title: Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy
Article Snippet: Enriched Tn/mem cells from leukapheresis products were stimulated with GMP Human T-expander CD3/CD28 DynabeadsTM (Dynal Biotech Cat#11141D) at a ratio of 1:3 (T cell:bead) overnight. .. Activated T cells were subsequently transduced with CD19R(EQ):CD28:ζ/EGFRt clinical construct at MOI=1 in RPMI 1640 containing 10% FBS and 5μg/ml protamine sulfate (Fresenius Kabi, 22905), 50U/mL rhIL-2 (Novartis Pharmaceuticals, NDC0078-0495-61), and 0.5 ng/mL rhIL-15 (CellGenix, 1013-050). .. Beginning 4 days after bead stimulation, CAR T cells were treated with rapamycin (50 nmol/L) (LC Laboratories, R-5000) or vehicle (DMSO) and refreshed with media containing rapamycin or vehicle every other day.



Similar Products

86
Novartis human il 2 rhil 2
Human Il 2 Rhil 2, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/2+human+il/pm42132875-357-75-79
Average 86 stars, based on 1 article reviews
human il 2 rhil 2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Clinigen Inc rhil 2
Rhil 2, supplied by Clinigen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/2+rhil/10__1097_slash_cji__0000000000000607-20-44-45
Average 86 stars, based on 1 article reviews
rhil 2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

96
R&D Systems rhil 7
Rhil 7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/Recombinant+Human+IL-2+Protein/pmc13089343-228-47-50
Average 96 stars, based on 1 article reviews
rhil 7 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
R&D Systems rhil 2
Rhil 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/Recombinant+Human+IL-2+Protein/pmc13089343-228-41-44
Average 96 stars, based on 1 article reviews
rhil 2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Novartis rhil 2
Rhil 2, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/2+rhil/us12590163-2096-34-38
Average 86 stars, based on 1 article reviews
rhil 2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Novartis recombinant human il 2 rhil 2
Recombinant Human Il 2 Rhil 2, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/2+human+il/pmc12982053-61-23-27
Average 86 stars, based on 1 article reviews
recombinant human il 2 rhil 2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Chiron Corporation rhil 2
Rhil 2, supplied by Chiron Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil+2/2+rhil/us12533338-31-16-18
Average 86 stars, based on 1 article reviews
rhil 2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results